@article{c3a86c9570264648962007defb7ac72d,
title = "Oncolytic virotherapy in veterinary medicine: Current status and future prospects for canine patients",
keywords = "Cancer, Canine cancer therapy, Oncolysis, Oncolytic virus, Target molecule, combination therapy",
author = "Patil, \{Sandeep S.\} and Ivaylo Gentschev and Ingo Nolte and Gregory Ogilvie and Szalay, \{Aladar A.\}",
note = "Funding Information: I. Gentschev and A.A. Szalay have interests in developing vaccinia virus as an oncolytic virus with Genelux Corporation, San Diego, USA. This work also was supported in part by grants from the Research and Development Division of Genelux Corporation, San Diego, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding Information: We like to thank J. Stritzker, Q. Zhang, N. G. Chen, Y. A. Yu and A. MacNeill for providing unpublished data to the authors and J. Stritzker, D. Haddad and B. Minev for critical reading of the manuscript. The original studies of I. Gentschev, I. Nolte and A.A. Szalay presented in this review were funded by Genelux Corporation, San Diego, USA. S. S. Patil is a graduate fellow and supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wuerzburg. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.",
year = "2012",
month = jan,
day = "4",
doi = "10.1186/1479-5876-10-3",
language = "English",
volume = "10",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
number = "1",
}